Today, not enough is known about the dynamics of how urban development can drive diabetes, or how it can deliver potential health benefits to city living.
To address this, in 2014 the Steno Diabetes Center Copenhagen,
University College London, and Novo Nordisk launched Cities Changing
Diabetes. The programme is designed to address the social and cultural
factors that can increase type 2 diabetes vulnerability among certain
people living in urban environments. Today, the programme has
established local partnerships in 22 cities.
The Cities Changing Diabetes programme has three interconnected
elements: Mapping Sharing Acting The Cities Changing Diabetes
programme enables cities to contextualise their own urban diabetes
situation, to set goals for halting the rise of type 2 diabetes in
their city, and to work across sectors and disciplines to unite
stakeholders behind a common cause.
Through the programme, participating cities can get a global
overview of the associated challenges and learn from possible
solutions tested in existing partner cities from around the
In each city, we start the programme by generating a body of collective knowledge about urban diabetes: what’s working today? Where are the challenges and priorities for the future?
We continuously share what is learnt and connect the dots between cities. This enables everyone involved to gain from the experience and knowledge of others and create solutions for their own local needs.
Together with our partners, we work to scale up solutions that target urban diabetes through health promotion and urban design, and enable us to drive action through the programme.